Sign In
Buy SNY
$42.37
-0.430 (-1.00%)
At Close: Jun 03, 2026
Sanofi Buys U.S. Partner Translate Bio For $3.2 Billion As Pharma Giant Bets Big On mRNA Tech
04:17am, Tuesday, 03'rd Aug 2021
Pfizer, BioNTech and Moderna used mRNA to build effective Covid-19 vaccines in record time, a feat Sanofi is keen to build upon in the future.
Sanofi to acquire U.S.-based Translate Bio in deal valued at $3.2 billion
01:41am, Tuesday, 03'rd Aug 2021
Sanofi to acquire U.S.-based Translate Bio in deal valued at $3.2 billion
Sanofi confirms $3.2 billion offer to buy U.S. biotech firm Translate Bio
01:28am, Tuesday, 03'rd Aug 2021
French drugmaker Sanofi said it had made a $3.2 billion offer to buy U.S. biotech company Translate Bio, as it bets on next-generation mRNA technology after setbacks in the COVID-19 vaccine race.
Exclusive-Sanofi offers to buy U.S. mRNA partner Translate Bio -sources
05:46pm, Monday, 02'nd Aug 2021
PARIS (Reuters) -Sanofi has offered to buy U.S. biotech company Translate Bio, two sources familiar with the situation said on Monday, as the French drugmaker bets on next-generation mRNA technology a
Sanofi SA (SNY) CEO Paul Hudson on Q2 2021 Results - Earnings Call Transcript
06:16pm, Thursday, 29'th Jul 2021
Sanofi SA (SNY) CEO Paul Hudson on Q2 2021 Results - Earnings Call Transcript
Sanofi (SNY) Q2 Earnings & Sales Beat, 2021 EPS View Raised
02:28pm, Thursday, 29'th Jul 2021
Sanofi (SNY) earnings and sales beat estimates in the second quarter of 2021. Dupixent and vaccines drive sales growth in the reported quarter.
Online availability of Sanofi's half-year financial report for 2021
12:24pm, Thursday, 29'th Jul 2021
Online availability of Sanofi's half-year financial report for 2021
Viatris gets FDA approval of first biosimilar version of Sanofi's insulin Lantus
08:12am, Thursday, 29'th Jul 2021
Shares of Viatris Inc. gained 3.3% in premarket trading on Thursday, the day after the Food and Drug Administration approved the first biosimilar verson of insulin glargine from Viatris and Biocon Bio
Sanofi Q2 Performance Benefits From Dupixent, Vaccines; Raises 2021 Profit Forecast
07:19am, Thursday, 29'th Jul 2021
Sanofi SA (NASDAQ: SNY) has raised its 2021 profit forecast after its vaccines and blockbuster eczema treatment Dupixent helped boost second-quarter results. Q2 2021 sales grew 6.55 Y/Y to €8.7 bi
Regeneron - Sanofi's Dupixent Improves Itch, Hives In Inflammatory Skin Disease Patients
07:06am, Thursday, 29'th Jul 2021
Sanofi SA (NASDAQ: SNY) and Regeneron Pharmaceuticals Inc's (NASDAQ: REGN) have announced topline results from Phase 3 trial evaluating Dupixent (dupilumab) in patients with moderate-to-severe ch
Sanofi raises profit forecasts after strong second quarter
01:39am, Thursday, 29'th Jul 2021
Sanofi raised its 2021 outlook after its vaccines and star eczema treatment Dupixent helped it post better-than-expected second-quarter results on Thursday.
Sanofi's Pompe Disease Enzyme Replacement Therapy Gets EMA's CHMP Backing
02:49pm, Tuesday, 27'th Jul 2021
The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Sanofi SA's (NASDAQ: SNY) avalglucosidase alfa for Pompe disease. The
7 Cheap Value Stocks to Buy for August 2021
02:23pm, Tuesday, 27'th Jul 2021
These cheap value stocks have the potential to provide shareholders with long-term growth that exceeds their current limiting valuations. The post 7 Cheap Value Stocks to Buy for August 2021 appeared
Sanofi-Regeneron's COPD Drug Fails In Mid-Stage Trial, But Shows Potential Benefit In Subgroup of Former Smokers
01:22pm, Thursday, 22'nd Jul 2021
Sanofi SA (NASDAQ: SNY) and Regeneron Pharmaceuticals Inc (NASDAQ: REGN) started their collaboration in chronic obstructive pulmonary disorder (COPD) to target all patients, and the data is pointin
15 European Dividend Aristocrats to Diversify Your Portfolio
01:47pm, Wednesday, 21'st Jul 2021
Plenty of investors focus in on dividends, and dividend aristocrats, but if those investors only look in the U.S. they could be missing out. The post 15 European Dividend Aristocrats to Diversify Your
